Optimization of the medical diagnostics and therapy managing in colorectal tumors using F-18-Deoxyglucose (FDG) positron emission tomography (PET) and gene expression data (GenPET Colon-2008).

Optimization of the medical diagnostics and therapy managing in colorectal tumors using F-18-Deoxyglucose (FDG) positron emission tomography (PET) and gene expression data (GenPET Colon-2008). - GenPET Colon

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00000329

Enrollment

Registered

2010-02-19

Start date

2010-06-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C18.0-C18.9

Interventions

Group 1: dynamic PET/CT (dPET/CT) with FDG prior to surgery due to a colorectal carcinoma

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with a histologically confirmed primary colorectal carcinoma

Exclusion criteria

Exclusion criteria: rejection of the examination by the patient diabetes mellitus acute psychosis and other diseases with limited possibilities to understand the examination pregnant women claustrophobic patients

Design outcomes

Primary

Measure	Time frame
recurrent free survival	—

Secondary

Measure	Time frame
individual survival	—

Countries

Germany

Contacts

Public ContactAntonia Dimitrakopoulou-Strauss

Deutsches Krebsforschungszentrum

ads@ads-lgs.de06221 422500

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026